Katherine Creeper

Great to see this in print! 👇🏼👇🏼👇🏼 Prevalence of Potentially Inappropriate Apixaban Prescribing Within a Single‐Centre Tertiary Hospital - Creeper - 2026 - Australasian Journal on Ageing - Wiley Online Library onlinelibrary.wiley.com/doi/10.1111/aj…

Catheter-based therapies are playing an increasingly important role in the care of pulmonary embolism. This article explores their place in the new guideline framework: jacc.org/doi/10.1016/j.… #JACC #PulmonaryEmbolism #CathLab @GBarnesMD

Impact of concurrent antiplatelet use on the safety and efficacy of th... sciencedirect.com/science/articl…

@TobyRichardsUEL 100% agree!

@KJClots Interesting that leg swelling and ulcer healing not impacted - don’t get me wrong I am a supporter but interested to see 2 year outcome and re intervention rates (these need tight follow up)

Endovascular Therapy for Post-Thrombotic Syndrome — A Randomized Trial | New England Journal of Medicine nejm.org/doi/full/10.10…

Presented at #ACC26: In patients with pulmonary embolism, ultrasound-facilitated, catheter-directed fibrinolysis led to a lower risk of a composite of major adverse outcomes than anticoagulation alone. Full HI-PEITHO trial results: nejm.org/doi/full/10.10… Editorial: Advanced Therapy for Intermediate-Risk Pulmonary Embolism nejm.org/doi/full/10.10… @ACCinTouch

👇🏼👇🏼👇🏼

Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism | New England Journal of Medicine nejm.org/doi/full/10.10…

this work shows that #apixaban would not be a suitable agent for breastfeeding women during the postnatal period, while #rivaroxaban shows significant promise due to low infant exposure and warrants further investigation. jthjournal.org/article/S1538-…

The heartbreaking and untimely passing of beloved actress, Catherine O’Hara, reminds us why the work to diagnose and treat pulmonary embolism is so critical. PERT Consortium sends our deepest sympathies to Ms. O’Hara’s family and loved ones during this difficult time. 💔 nytimes.com/2026/02/09/mov…

Thrombosis UK has co-created this leaflet for people with mechanical/ metallic heart valves, who are considering pregnancy or are pregnant. Please click the link thrombosisuk.org/wp-content/upl… #TUK #ThrombosisUK #pregnancy

Prevention and treatment of #thrombosis in patients with decompensated #cirrhosis jthjournal.org/article/S1538-…

You’re smashing it @PortiaSmallbone! Congrats!

Very proud to present our work on clonal dynamics of relapse in FLT-ITD mutant AML post HCT. Three relapse archetypes emerging: FLT3 persistence, loss and ITD/TKD change - all with their own therapeutic implications. #ASH25 #amlsm #bmtsm @MDAndersonNews @sanamloghavi

Great to finally see this in print! ⁦@TH_Journal⁩ share.google/cRbudLUOGpUphV…

Live @TCTConference First podium presentation of the #STORM-PE trial!! First RCT of thrombectomy vs Anticoag ever!! Thank you to @crfheart @PenVascular @PERTConsortium for advancing the field

You know you’re in Perth when the skyline reads Woodside, Rio Tinto, BHP…but we’re for #Blood2025

New episode of The #Pathology Report is out now 🎧 Tune in to hear A/Prof Dan Owens explore the latest on managing bleeding with Prof Beverley Hunt and Dr Pratheepan Puvanakumar @bhwords @do315 rcpa.me/The-Pathology-…

📄🧠Paper of the Month: Explore the new practice-facing statement on Cerebral Amyloid Angiopathy from the International #CAA Association & @WorldStrokeOrg 👉@opontesnetoMD commentary: world-stroke-academy.org/news/the-paper… 👉@IntJStroke original: journals.sagepub.com/doi/10.1177/17… #StrokeEducation #CAA